PS Channel


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ETF Introduction: IBB — iShares Nasdaq Biotechnology ETF
- Monday, April 6, 5:28 PM

Description to the Nasdaq Biotechnology Index Fund, traded under ticker symbol IBB: This ETF is a fund, created in February 2001, that corresponds to the price and yield performance, before fees and expenses, of companies primarily in the biotech sector, as represented by the NASDAQ Biotechnology Index. The underlying index includes securities of Nasdaq listed companies classified according to the Industry Classification Benchmark as either Biotech or Pharma which also meet other eligibility criteria.

Fund Name: iShares Nasdaq Biotechnology ETF
Issuer: iShares
Total Net Assets: $9,749,344,386
Inception: 02/05/2001
Related Index: NASDAQ Biotechnology Index (NBI)
ETF Category: Health
Expense Ratio: 0.47%
Net Asset Value: $109.42
Recent NAV Discount: -0.01%
NAV Symbol: IBB.NV
Number of Holdings: 197
Annualized Yield: 0.28%
Annualized Distribution: 0.306
Stock Weight Amount
Gilead Sciences 8.02% $781,678,169
Amgen 7.60% $740,735,092
Biogen Inc 7.39% $720,712,061
Celgene 6.99% $681,936,810
Regeneron Pharmaceuticals 4.43% $431,501,200
List of all 199 stocks held by IBB »




10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs



10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
Top 10 Analyst Rated Consumer Stocks
Top 10 Analyst Rated Healthcare Stocks
Top 10 Analyst Rated Technology Stocks

Quotes delayed 20 minutes

Buy (3.24 out of 4)
87th percentile
(ranked higher than approx. 87% of all etfs covered)
Based on
ETF Assets
IVV $150,598,342,145
EFA $79,250,362,903
AGG $53,492,475,182
IEFA $49,733,934,712
IEMG $46,342,962,754
List of all 343 others »
Shares Short 8,840,900
Chg. from Last Month -528,100
Shares Outstanding 88,000,000
% of Shares Short 10.05%
Days to Cover 3.2
Based on data powered by ShortSqueeze.com


PARTNER NEWS:

Thu, Dec 28, 1:27 PM, Zacks

Teucrium plans for an Emerging Medical Agriculture Index Fund. Does this hint at a marijuana ETF?

Wed, Dec 13, 11:41 AM, Zacks

A few reasons why you should buy value biotech ETFs for 2018

Top Finances News

kansas city southern railroad stock canadian natural resources dividend history dow chemical stock price prediction agilent technologies stock price history what is berkshire hathaway b stock bed bath and beyond stock symbol market vectors junior gold miners index proctor and gamble stock quote miller brewing company stock symbol natural grocer by vitamin cottage sun life financial canada stock price fifth third bank stock quote

IBB | iShares Nasdaq Biotechnology ETF | PC Channel | pomogistarikam.ru | Copyright © 2009 - 2018, All Rights Reserved

Nothing in PC Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following and . and ETF videos powered by . Quote data delayed at least 20 minutes; , and . ; .